Attributable mortality of nosocomial candidemia, revisited. - Wikidata - wikimedia - TriplyDB

Attributable mortality of nosocomial candidemia, revisited.

Attributable mortality of nosocomial candidemia, revisited.

http://www.wikidata.org/entity/Q44386169

about

Bench-to-bedside review: therapeutic management of invasive candidiasis in the intensive care unit Genetic and phenotypic intra-species variation in Candida albicans Invasive candidiasis as a cause of sepsis in the critically ill patient Central venous catheter (CVC) removal for adult patients with candidaemia Patient isolation measures for infants with candida colonization or infection for preventing or reducing transmission of candida in neonatal units Patient isolation measures for infants with candida colonization or infection for preventing or reducing transmission of candida in neonatal units Endogenous thrombospondin-1 regulates leukocyte recruitment and activation and accelerates death from systemic candidiasis Effectiveness of anidulafungin in eradicating Candida species in invasive candidiasis.Phase 2, randomized, dose-ranging study evaluating the safety and efficacy of anidulafungin in invasive candidiasis and candidemia Identification and characterization of a previously undescribed family of sequence-specific DNA-binding domains Central venous catheter (CVC) removal for patients of all ages with candidaemia The Role of Autophagy-Related Proteins in Candida albicans Infections Emerging drugs and vaccines for candidemia All you need is light: antimicrobial photoinactivation as an evolving and emerging discovery strategy against infectious disease Candida colonization index and subsequent infection in critically ill surgical patients: 20 years later Association of genotypes with infection types and antifungal susceptibilities in Candida albicans as revealed by recent molecular typing strategies Epidemiology and risk factors for invasive candidiasis Control and manipulation of pathogens with an optical trap for live cell imaging of intercellular interactions Flow Cytometry-Based Method To Detect Persisters in Candida albicans.Validation of the tetracycline regulatable gene expression system for the study of the pathogenesis of infectious disease The conserved Candida albicans CA3427 gene product defines a new family of proteins exhibiting the generic periplasmic binding protein structural fold Candida albicans infection of Caenorhabditis elegans induces antifungal immune defenses Real-time PCR in clinical microbiology: applications for routine laboratory testing.Probing the Active Site ofCandida glabrataDihydrofolate Reductase with High Resolution Crystal Structures and the Synthesis of New Inhibitors Crystal Structures of Candida albicans Dihydrofolate Reductase Bound to Propargyl-Linked Antifolates Reveal the Flexibility of Active Site Loop Residues Critical for Ligand Potency and Selectivity Determination of mRNA half-lives in Candida albicans using thiolutin as a transcription inhibitor Comparison of echinocandin antifungals Development of a high-throughput Candida albicans biofilm chip A new tool to quantify receptor recruitment to cell contact sites during host-pathogen interaction Nosocomial candidemia; risk factors and prognosis revisited; 11 years experience from a Norwegian secondary hospital Identification of New Antifungal Compounds Targeting Thioredoxin Reductase of Paracoccidioides Genus Antioxidant, Antimicrobial and Cytotoxic Properties as Well as the Phenolic Content of the Extract from Hancornia speciosa Gomes Active and passive immunization with rHyr1p-N protects mice against hematogenously disseminated candidiasis Activity of crude extracts from Brazilian cerrado plants against clinically relevant Candida species Epidemiology of invasive candidiasis: a persistent public health problem Multicenter evaluation of Candida QuickFISH BC for identification of Candida species directly from blood culture bottles.Interaction of Candida albicans with adherent human peripheral blood mononuclear cells increases C. albicans biofilm formation and results in differential expression of pro- and anti-inflammatory cytokines.Fungemia in a Spanish hospital: the role of Candida parapsilosis over a 15-year period.Excess mortality, hospital stay, and cost due to candidemia: a case-control study using data from population-based candidemia surveillance.Characteristics and risk factors for 28-day mortality of hospital acquired fungemias in ICUs: data from the EUROBACT study

P2860

Q21194915-41F1E506-41E2-4E3D-A1A4-19D0C496E8F3 Q21999063-DEA4586A-C6D1-4319-9979-4479F6180732 Q22305429-3826D893-DBFF-4853-B497-1220E5BE14CD Q24195090-54A69EC0-5C4A-4973-B7D1-67F6638E74E9 Q24235328-3B094655-CA86-4551-A148-D486F635CD32 Q24243803-A542B92B-C09B-4DCE-A1CF-D166B3B600DB Q24303620-5CDC3743-7C23-43AC-A87B-0B99B91314EE Q24537282-8BE83E7F-24BF-42BE-96D1-2D02D3532940 Q24563657-4220BAB7-4D5B-44FC-89B3-CDF24D6F572E Q24628877-02708842-F1A7-49B7-9D18-F8D194FA2C80 Q26471135-B03D5C98-138E-432A-AAFF-818CF7597B81 Q26752567-8DA56974-A316-4695-8959-057EDD11D912 Q26828993-1A46465C-BA45-4179-B651-F5E4A625E7C9 Q26830053-F09047B2-F51B-4CBC-88F0-FBEF1ACE9643 Q27012454-672A15D9-FD69-4751-8397-E3D271FD9841 Q27023720-1C703243-AD0E-4C23-8F08-F0CFAC87504C Q27024911-B01742DB-BAB4-424A-87C4-34BBFBD6F2D8 Q27313251-D38DCC19-0BA3-4018-A80C-403E4DE2414B Q27324379-6F9F9FAF-8C65-449A-B4D6-9FC8937A3D65 Q27338028-2CD44629-F2E7-4333-9810-171148951831 Q27348287-86D4A12A-BA4A-463C-AF83-41715E54EBA8 Q27349803-94FF7FAD-354D-4583-AD8B-D81C2C5A93C4 Q27472851-92BD16FA-5334-410E-840A-42F549B81151 Q27653450-379436A4-DB7A-4662-B2D1-B9031061F0C2 Q27670663-4F55C96C-1373-408D-A4B1-D4236708AAF2 Q28268148-3B3A9DBD-F374-4AEC-93AC-5969F9D516CF Q28273738-F3DBFE6A-6D35-4A02-8578-66B0127CAF2E Q28477874-398DBFC3-33EA-49A7-BF15-8CEA478D7DD2 Q28539165-5BAE18A5-D093-404C-B4BF-5385A961095E Q28541447-21B97AC3-F7A2-4C26-96E5-5724EB7E4C44 Q28550999-773D4B6B-B557-4172-A95B-EF6F6F6F90F3 Q28554670-086323B7-E534-4FF3-BC16-0E3C0818A210 Q28744094-B65703EB-ABAD-4B36-9481-B329D27D62D7 Q28830609-F943D020-7C14-4556-BD0D-B51A3A5F1F36 Q29616758-E53CE753-5FEC-44BD-A584-4DF74FFBFD8B Q30300387-48DFF36F-B159-4B62-A91B-96CBC3148A88 Q30479433-B64F4403-F87A-489C-B6F8-A61055C1EDB2 Q30808061-5C1126D4-72F7-4212-8DC2-A3FBD16EC460 Q30994297-166F9500-F9ED-4FD9-BE9C-EF4618B30B04 Q31054881-30736919-D5E9-4CD1-8B81-453D6F53DA07

P2860

Attributable mortality of nosocomial candidemia, revisited.

http://www.wikidata.org/entity/Q44386169

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

Attributable mortality of nosocomial candidemia, revisited.

@en

Attributable mortality of nosocomial candidemia, revisited.

@nl

type

label

Attributable mortality of nosocomial candidemia, revisited.

@en

Attributable mortality of nosocomial candidemia, revisited.

@nl

prefLabel

Attributable mortality of nosocomial candidemia, revisited.

@en

Attributable mortality of nosocomial candidemia, revisited.

@nl

P1433

Q44386169-06D7B4A7-CD60-416D-8BEF-403140861A83

P1476

Q44386169-2FBA8F06-65CF-4892-8990-405055376184

P2093

Q44386169-15C75AD9-0167-4D36-884B-170DA3A63BE8

Q44386169-5E2DBAE2-A5A5-427F-AC80-265F93FB1DE5

Q44386169-95E6CC96-1E93-42F7-B197-4D7E3387652E

Q44386169-B97A1BE0-4F6F-47C2-A49A-E9A6EF56C545

Q44386169-C1484FD1-917D-419C-85C1-ACDD70F2F479

Q44386169-CB08E563-1B2C-4D3E-BA5D-11CAEAAB001A

P2860

Q44386169-04E38228-AB01-4DBB-8B80-31023038D99F

Q44386169-29A87387-50CC-449D-83F0-7D7BF46992EE

Q44386169-2DC767DC-9119-4CEC-84FE-DFFD23A265C1

Q44386169-3389DE8C-ACD1-41F2-890E-9B180745D0A8

Q44386169-365F4291-18D1-4106-96AB-B8B60686E36B

Q44386169-3799D70B-7A87-4FFA-8149-69BB4D0D2947

Q44386169-5F30A109-26F2-4FF8-BBCD-3693E8FEC486

Q44386169-615EAA6F-8888-4E1F-9DAE-E5BE6353D10C

Q44386169-64EAA9E7-6B81-45D2-947D-320ABADE29B1

Q44386169-696449A6-4C78-45E1-A6AC-723C7F4CBA65

P304

Q44386169-E86BF2CA-9213-4C85-88EF-3B2816A14166

P31

Q44386169-FDB7360C-C43D-49C1-9BD0-9E2A6A9FC68C

P356

Q44386169-87325D09-8554-4F48-9619-FA2893BA71C3

P407

Q44386169-099E2194-86E9-4447-BE51-927AEAEDBA57

P433

Q44386169-F685C9CD-1D7A-4BC5-9A36-A5FBF50A4E49

P478

Q44386169-A6E45FBE-636B-4C8E-9302-DF672E6582FE

P50

Q44386169-124857A5-54BF-45F4-8DF5-93BD5D8C1D2D

Q44386169-7CE9ACE0-0BB4-49C9-990D-C3C6BF66A18A

Q44386169-A349C6BD-F0FC-4CA1-93ED-1F832B17A526

P577

Q44386169-025CF7FF-58C7-4DB6-A449-40B47E4EBD50

P5875

Q44386169-A162C1C5-1F88-4B21-848B-649839B626B5

P698

Q44386169-1CA76667-8193-4B5A-A013-42D30D08285F

P356

P1433

Clinical Infectious Diseases

P1476

Attributable mortality of nosocomial candidemia, revisited.

@en

P2093

Jeff Vande Berg

http://www.w3.org/2001/XMLSchema#string

Jianfang Hu

http://www.w3.org/2001/XMLSchema#string

Kathleen Lee

http://www.w3.org/2001/XMLSchema#string

Michael Pfaller

http://www.w3.org/2001/XMLSchema#string

Olafur Gudlaugsson

http://www.w3.org/2001/XMLSchema#string

Shane Gillespie

http://www.w3.org/2001/XMLSchema#string

P2860

A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from January 1990-May 1999, issued June 1999. A report from the NNIS System.

Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America.

Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997.

Role of sentinel surveillance of candidemia: trends in species distribution and antifungal susceptibility.

Microbiological factors influencing the outcome of nosocomial bloodstream infections: a 6-year validated, population-based model.

Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality.

Effect of an education program on decreasing catheter-related bloodstream infections in the surgical intensive care unit.

Hospital-acquired fungemia. Its natural course and clinical significance.

P304

1172-1177

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/378745

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P50

Daniel J. Diekema

Loreen Herwaldt

P577

2003-10-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

9051941

http://www.w3.org/2001/XMLSchema#string

P698

14557960

http://www.w3.org/2001/XMLSchema#string